This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (130)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Lipids and Lipid Disorders  • Alert me on articles by topic

Patrick McBride, MD, MPH; Helmut G. Schrott, MD; Mary Beth Plane, PhD; Gail Underbakke, MS, RD; Roger L. Brown, PhD

Arch Intern Med. 1998;158:1238-1244.

Background  Clinical trials demonstrate significant benefit from cholesterol management for patients with cardiovascular disease (CVD). National guidelines recommending goals for screening and treatment were published in 1993 and widely disseminated. This study examines cholesterol screening and management by primary care physicians after the guidelines were released.

Methods  Medical records and patient surveys provided data for 603 patients with CVD, aged 27 to 70 years, from 45 practices in 4 states during 1993 to 1995. Physician surveys measured estimated performance and other variables. Physician and patient factors associated with adherence, or lack of adherence, to national guidelines were examined using univariate and multivariate analyses.

Results  A total of 199 patients (33%) with CVD were not screened with lipid panels, 271 patients (45%) were not receiving dietary counseling, and 404 (67%) were not receiving cholesterol medication. Only 84 patients (14%) with CVD had achieved the recommended low-density lipoprotein level of less than 2.58 mmol/L (100 mg/dL) and 302 (50%) had triglyceride levels lower than 2.26 mmol/L (200 mg/dL). Patients with a revascularization history and higher low-density lipoprotein and/or triglyceride levels were more likely to receive treatment, but other patient factors, including CVD risk factors, did not predict treatment. Physician specialty was not associated with differences in treatment, but physicians in practice for fewer years ordered more lipid panels.

Conclusions  Most patients with CVD in primary care were not receiving cholesterol screening and management as recommended by the National Cholesterol Education Program guidelines in the 2 years after their release. Increasing cholesterol screening and treatment should be a priority for practice quality improvement and could result in significant reductions in CVD events for high-risk patients.

From the HEART Preventive Cardiology Program, University of Wisconsin Medical School, Madison (Drs McBride, Plane, and Brown and Ms Underbakke); and the Department of Preventive Medicine, University of Iowa School of Medicine, Iowa City (Dr Schrott).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quality of Lipid Management in Outpatient Care: A National Study Using Electronic Health Records
Gill and Yingxia Chen
American Journal of Medical Quality 2008;23:375-381.
ABSTRACT  

Using Computer-Based Decision Support to Close the "Know Do" Gap in Lipid-Lowering Therapy
Avorn and Choudhry
Circulation 2008;117:336-337.
FULL TEXT  

Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study
Geller et al.
Eur Heart J 2007;28:3051-3058.
ABSTRACT | FULL TEXT  

Patient Knowledge of Coronary Risk Profile Improves the Effectiveness of Dyslipidemia Therapy: The CHECK-UP Study: A Randomized Controlled Trial
Grover et al.
Arch Intern Med 2007;167:2296-2303.
ABSTRACT | FULL TEXT  

Shaping the Future of Academic Health Centers: The Potential Contributions of Departments of Family Medicine
Newton and DuBard
Ann Fam Med 2006;4:S2-S11.
ABSTRACT | FULL TEXT  

Trends in the Prevalence, Awareness, Treatment, and Control of Cardiovascular Disease Risk Factors among Noninstitutionalized Patients with a History of Myocardial Infarction and Stroke
Muntner et al.
Am J Epidemiol 2006;163:913-920.
ABSTRACT | FULL TEXT  

Dyslipidemia Prevalence, Treatment, and Control in the Multi-Ethnic Study of Atherosclerosis (MESA): Gender, Ethnicity, and Coronary Artery Calcium
Goff et al.
Circulation 2006;113:647-656.
ABSTRACT | FULL TEXT  

Lipid Testing and Lipid-Lowering Therapy in Hospitalized Ischemic Stroke and Transient Ischemic Attack Patients: Results From a Statewide Stroke Registry
Mullard et al.
Stroke 2006;37:44-49.
ABSTRACT | FULL TEXT  

Lipids and CVD management: towards a global consensus
Ballantyne et al.
Eur Heart J 2005;26:2224-2231.
ABSTRACT | FULL TEXT  

Combined training of GPs and practice-assistants on peripheral arterial disease: positive effects after six months
Willigendael et al.
Fam Pract 2005;22:520-522.
ABSTRACT | FULL TEXT  

Opportunity for Intervention to Achieve American Heart Association Guidelines for Optimal Lipid Levels in High-Risk Women in a Managed Care Setting
Mosca et al.
Circulation 2005;111:488-493.
ABSTRACT | FULL TEXT  

Physicians' attitudes to the pharmacological treatment of patients with stable angina pectoris
Beaulieu et al.
QJM 2005;98:41-51.
ABSTRACT | FULL TEXT  

Is Lipid-Lowering Therapy Underused by African Americans at High Risk of Coronary Heart Disease Within the VA Health Care System?
Woodard et al.
Am. J. Public Health 2004;94:2112-2117.
ABSTRACT | FULL TEXT  

Dyslipidemias and HMG-CoA Reductase Inhibitor Prescription in Heart Transplant Recipients
de Denus et al.
The Annals of Pharmacotherapy 2004;38:1136-1141.
ABSTRACT | FULL TEXT  

In-Hospital Initiation of Lipid-Lowering Therapy After Coronary Intervention as a Predictor of Long-term Utilization: A Propensity Analysis
Aronow et al.
Arch Intern Med 2003;163:2576-2582.
ABSTRACT | FULL TEXT  

Current Management Issues Associated with Community-Acquired Pneumonia
Cregin
Journal of Pharmacy Practice 2003;16:324-334.
ABSTRACT  

Primary care in the United States: Innovations in primary care in the United States * Commentary: What can primary care in the United States learn from the United Kingdom?
Bodenheimer et al.
BMJ 2003;326:796-799.
FULL TEXT  

Screening for Statin-Related Toxicity: The Yield of Transaminase and Creatine Kinase Measurements in a Primary Care Setting
Smith et al.
Arch Intern Med 2003;163:688-692.
ABSTRACT | FULL TEXT  

Automating Complex Guidelines for Chronic Disease: Lessons Learned
Maviglia et al.
J. Am. Med. Inform. Assoc. 2003;10:154-165.
ABSTRACT | FULL TEXT  

Behavioral Medicine in the Prevention and Treatment of Cardiovascular Disease
Graves and Miller
Behav Modif 2003;27:3-25.
ABSTRACT  

Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Lalouschek et al.
Stroke 2003;34:105-110.
ABSTRACT | FULL TEXT  

Improving Primary Care for Patients With Chronic Illness
Bodenheimer et al.
JAMA 2002;288:1775-1779.
ABSTRACT | FULL TEXT  

Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study
Wei et al.
Heart 2002;88:229-233.
ABSTRACT | FULL TEXT  

A Primary Care Home for Americans: Putting the House in Order
Grumbach and Bodenheimer
JAMA 2002;288:889-893.
ABSTRACT | FULL TEXT  

A Randomized Trial of the Effect of Community Pharmacist Intervention on Cholesterol Risk Management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)
Tsuyuki et al.
Arch Intern Med 2002;162:1149-1155.
ABSTRACT | FULL TEXT  

Use of Cholesterol-Lowering Therapy by Elderly Adults After Myocardial Infarction
Ayanian et al.
Arch Intern Med 2002;162:1013-1019.
ABSTRACT | FULL TEXT  

Disparities in the Diagnosis and Pharmacologic Treatment of High Serum Cholesterol by Race and Ethnicity: Data From the Third National Health and Nutrition Examination Survey
Nelson et al.
Arch Intern Med 2002;162:929-935.
ABSTRACT | FULL TEXT  

A Community-Wide Survey of Physician Practices and Attitudes Toward Cholesterol Management in Patients With Recent Acute Myocardial Infarction
Yarzebski et al.
Arch Intern Med 2002;162:797-804.
ABSTRACT | FULL TEXT  

Physician Advice, Patient Actions, and Health-Related Quality of Life in Secondary Prevention of Stroke Through Diet and Exercise * The Physician's Role in Helping Patients to Increase Physical Activity and Improve Eating Habits
Greenlund et al.
Stroke 2002;33:565-571.
ABSTRACT | FULL TEXT  

Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease
Ades
NEJM 2001;345:892-902.
FULL TEXT  

Presidential address: quality of cardiovascular care in the U.S.
Beller
J Am Coll Cardiol 2001;38:587-594.
FULL TEXT  

Lipid Disorders : Justification of Methods and Goals of Treatment
Braunstein et al.
Chest 2001;120:979-988.
ABSTRACT | FULL TEXT  

Translation of nutritional sciences into medical education: the Nutrition Academic Award Program
Pearson et al.
Am. J. Clin. Nutr. 2001;74:164-170.
ABSTRACT | FULL TEXT  

Ineffective Secondary Prevention in Survivors of Cardiovascular Events in the US Population: Report From the Third National Health and Nutrition Examination Survey
Qureshi et al.
Arch Intern Med 2001;161:1621-1628.
ABSTRACT | FULL TEXT  

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme
Eur Heart J 2001;22:554-572.
ABSTRACT  

Improving Lipid Evaluation and Management in Medicare Patients Hospitalized for Acute Myocardial Infarction
Malach et al.
Arch Intern Med 2001;161:839-844.
ABSTRACT | FULL TEXT  

Use and Monitoring of "Statin" Lipid-Lowering Drugs Compared With Guidelines
Abookire et al.
Arch Intern Med 2001;161:53-58.
ABSTRACT | FULL TEXT  

Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction : Data From the National Registry of Myocardial Infarction 3
Fonarow et al.
Circulation 2001;103:38-44.
ABSTRACT | FULL TEXT  

Use of Simvastatin Treatment in Patients With Combined Hyperlipidemia in Clinical Practice
Vicari et al.
Arch Fam Med 2000;9:898-905.
ABSTRACT | FULL TEXT  

Self-reported Hypertension Treatment Practices Among Primary Care Physicians: Blood Pressure Thresholds, Drug Choices, and the Role of Guidelines and Evidence-Based Medicine
Hyman and Pavlik
Arch Intern Med 2000;160:2281-2286.
ABSTRACT | FULL TEXT  

Sex Bias and Underutilization of Lipid-Lowering Therapy in Patients With Coronary Artery Disease at Academic Medical Centers in the United States and Canada
Miller et al.
Arch Intern Med 2000;160:343-347.
ABSTRACT | FULL TEXT  

Clinical Goals and Performance Measures for Cholesterol Management in Secondary Prevention of Coronary Heart Disease
Lee et al.
JAMA 2000;283:94-98.
ABSTRACT | FULL TEXT  

Physician Noncompliance With the 1993 National Cholesterol Education Program (NCEP-ATPII) Guidelines • Response
Danias et al.
Circulation 1999;99 :3323-3326.
FULL TEXT  

The Movement for Improved Quality in Health Care
Bodenheimer
NEJM 1999;340:488-492.
FULL TEXT